Philip R

No ORCID on file · 1 paper in corpus

2013

Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels.

Journal of cancer research and clinical oncology ·doi:10.1007/s00432-013-1501-6

PurposeCA-125 has been a valuable marker for detecting ovarian cancer, however, it is not sensitive enough to detect early-stage disease and not specific to ovarian cancer. The purpose of our study was to identify autoantibody markers that …